Please login to the form below

Pharma and NHS working together for patients - the IBD Registry Industry Working Group

We hear a lot from pharma about patient-centricity these days, and rightly so. But there are many ways of putting this important principle into practice, and they don’t have to be complicated or expensive.
We hear a lot from pharma about patient-centricity these days, and rightly so. But there are many ways of putting this important principle into practice, and they don’t have to be complicated or expensive. 

Recently, we spoke to members of the IBD Registry Industry Working Group about what they’ve achieved in their first year, and whether or not it’s been worthwhile. It’s a very simple idea: the Registry executive team has clinical and academic expertise aplenty, industry colleagues contribute insights on how best to engage with pharma, and business development strategies to accelerate Registry participation. 

The group’s activities have been fruitful, but perhaps more interesting still are the reflections on the experience. Members are proud of the way that companies have set aside commercial rivalries in order to support clinicians and patients, and the Registry chair concluded: “My message to pharma is, more of the same please!”


You can watch the video here: http://dovetailstrategies.com/our-work/case-studies/pharma-and-nhs-working-together-for-patients-the...




12th March 2018

Share

Tags

Company Details

Dovetail

020 3176 6435

Contact Website

Address:
Vox Studios
1-45 Durham Street
London
SE11 5JH
United Kingdom

Latest content on this profile

What's the secret to leadership in joint working?
Dovetail Director Claire Munro on effective leadership strategies that drive results in joint working between pharma and clinical groups.
Dovetail
IBD Registry appoints first CEO

Dovetail
Impact of data sharing
With the General Data Protection Regulation (GDPR) on the horizon, the Cambridge Analytica scandal has provided a stark reminder of the importance of data protection laws.
Dovetail
Value proposition development
Pharma companies need to demonstrate value to the NHS, so developing a clear statement to articulate that value to customers is a vital element of the marketing mix.
Dovetail
Joined-up thinking on anaemia
Iron deficiency anaemia is very common in inflammatory bowel disease (IBD) and can seriously reduce people’s quality of life, but it’s often under-treated.
Dovetail
Pharma and NHS working together for patients - the IBD Registry Industry Working Group
We hear a lot from pharma about patient-centricity these days, and rightly so. But there are many ways of putting this important principle into practice, and they don’t have to be complicated or expensive.
Dovetail